在子宫外表达DOCK8调节 lysosome介导的胰腺瘤细胞入侵
Omar L Gutierrez-Ruiz1, Katherine M Johnson2, Eugene W Krueger2
1Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN 55905, USA.
Cell reports
|August 31, 2023
概括
在胰腺癌中的瘤性KRAS增强了溶酶体活性. 研究人员发现,细胞动化8 (DOCK8) 的献身者通过调节 lysosomes 和 cathepsin B 来驱动侵袭,影响瘤转移.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 细胞生物学 细胞生物学
背景情况:
- 放大 lysosome 活动是胰腺管道腺癌 (PDAC) 的一个关键特征.
- 瘤性KRAS驱动PDAC中的瘤生长和转移,但涉及溶酶体的潜在机制尚未完全理解.
研究的目的:
- 研究瘤性KRAS影响 lysosome活动并促进PDAC.入侵的机制.
- 确定参与KRAS介导的溶酶体调节的关键蛋白质及其在胰腺癌进展中的作用.
主要方法:
- 进行比较的蛋白质组学,以识别在化体上丰富的蛋白质,在存在瘤性KRAS时.
- 在体外和体内测试以评估PDAC细胞入侵中细胞动化8 (DOCK8) 献体的作用.
- 对 lysosomal 形态,运动性,actin 聚合和 cathepsin B 活性进行分析.
主要成果:
- 瘤性KRAS丰富了 lysosomes 上的瓜核酸交换因子 (GEF) DOCK8.
- 在PDAC中异常的DOCK8表达通过调节 lysosome大小,运动性和actin聚合,促进细胞入侵.
- DOCK8增强了 lysosomal cathepsin B 的活性,导致细胞外基质降解和 PDAC 细胞侵入性增加.
结论:
- 宫外DOCK8表达是KRAS介导的溶酶体调节和胰腺癌侵袭的重要驱动因素.
- DOCK8代表了抑制胰腺癌转移的潜在治疗标.
相关概念视频
01:35Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
01:22PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K